PEDIATRICS Vol. 121 No. 2 February 2008, pp. 419-432 (doi:10.1542/10.1542/peds.2007-3283)
CLINICAL REPORT |
Surfactant-Replacement Therapy for Respiratory Distress in the Preterm and Term Neonate
Respiratory failure secondary to surfactant deficiency is a major cause of morbidity and mortality in preterm infants. Surfactant therapy substantially reduces mortality and respiratory morbidity for this population. Secondary surfactant deficiency also contributes to acute respiratory morbidity in late-preterm and term neonates with meconium aspiration syndrome, pneumonia/sepsis, and perhaps pulmonary hemorrhage; surfactant replacement may be beneficial for these infants. This statement summarizes indications, administration, formulations, and outcomes for surfactant-replacement therapy. The impact of antenatal steroids and continuous positive airway pressure on outcomes and surfactant use in preterm infants is reviewed. Because respiratory insufficiency may be a component of multiorgan dysfunction, preterm and term infants receiving surfactant-replacement therapy should be managed in facilities with technical and clinical expertise to administer surfactant and provide multisystem support.
Key Words: surfactant antenatal steroids respiratory distress syndrome meconium aspiration syndrome neonatal pneumonia neonatal sepsis congenital diaphragmatic hernia pulmonary hemorrhage persistent pulmonary hypertension preterm term
Abbreviations: RR—relative risk CI—confidence interval NNT—number needed to treat
The following policy statement has been revised:
- Surfactant Replacement Therapy for Respiratory Distress Syndrome
Pediatrics 103: 684-685.[Full Text]
This article has been cited by other articles:
![]() |
J. B. Warren and J. M. Anderson Core Concepts: Respiratory Distress Syndrome NeoReviews, July 1, 2009; 10(7): e351 - e361. [Abstract] [Full Text] [PDF] |
||||
![]() |
D G Sweet and H L Halliday The use of surfactants in 2009 Arch. Dis. Child. Ed. Pract., June 1, 2009; 94(3): 78 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. E. Truog 21st-Century Use for Surfactant? Pediatrics, January 1, 2009; 123(1): 173 - 174. [Full Text] [PDF] |
||||
![]() |
M. K. Lal and S. K. Sinha Review: Surfactant respiratory therapy using Surfaxin/sinapultide Therapeutic Advances in Respiratory Disease, October 1, 2008; 2(5): 339 - 344. [Abstract] [PDF] |
||||
![]() |
F. Moya, S. Sinha, and R. B. D'Agostino Sr Surfactant-Replacement Therapy for Respiratory Distress Syndrome in the Preterm and Term Neonate: Congratulations and Corrections Pediatrics, June 1, 2008; 121(6): 1290 - 1291. [Full Text] [PDF] |
||||
![]() |
W. A. Engle and A. R. Stark Surfactant-Replacement Therapy for Respiratory Distress Syndrome in the Preterm and Term Neonate: Congratulations and Corrections: In Reply Pediatrics, June 1, 2008; 121(6): 1291 - 1292. [Full Text] [PDF] |
||||
eLetters:
Read all eLetters
- Surfactant Prophylaxis in the Small but Stable Premature
- Steve Piecuch, MD, MPH
- Pediatrics Online, 15 Feb 2008 [Full text]








